Camille Locht

Dr. Camille Locht

Inserm U1019
+1
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2008 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
Thierry WirthThierry Wirth
Thierry Wirth
FHFalk Hildebrand
Falk Hildebrand
CACaroline Allix-Béguec
Caroline Allix-Béguec
FWFlorian Wölbeling
Florian Wölbeling
TKTanja Kubica
Tanja Kubica
Stefan NiemannStefan Niemann
Stefan Niemann
The evolutionary timing and spread of the Mycobacterium tuberculosis complex (MTBC), one of the most successful groups of bacterial pathogens, remains largely unknown. Here, using mycobacterial tandem repeat sequences as genetic markers, we show that the MTBC consists of two independent clades, one composed exclusively of M. tuberculosis lineages from humans and the other composed of both animal and human isolates. The latter also likely derived from a human pathogenic lineage, supporting the hypothesis of an original human host. Using Bayesian statistics and experimental data on the variability of the mycobacterial markers in infected patients, we estimated the age of the MTBC at 40,000 years, coinciding with the expansion of “modern” human populations out of Africa. Furthermore, coalescence analysis revealed a strong and recent demographic expansion in almost all M. tuberculosis lineages, which coincides with the human population explosion over the last two centuries. These findings thus unveil the dynamic dimension of the association between human host and pathogen populations. The causative agents of tuberculosis, grouped in the Mycobacterium tuberculosis complex, have infected one-third of the present human population and a wide range of other mammals. However, paradigmatic questions, such as why, where and when the disease began and expanded, have largely remained unanswered. In this study, we provide genetic evidence indicating that the most common ancestor of the bacterial complex emerged some 40,000 years ago from its progenitor in East Africa, the region from where modern human populations disseminated around the same period. This initial step was followed 10,000 to 20,000 years later by the radiation of two major lineages, one of which spread from human to animals. In more recent years (approximately 180 years ago), coinciding with the human population explosion and the industrial revolution, the human-associated pathogen lineages have strongly expanded. These results thus reveal the strikingly parallel demographic evolution between humans and one of their primary pathogens.

6 January 2013 in Nature Genetics
Verified
Journal Article
Open access
PDF file
PSPhilip Supply
Philip Supply
MMMichael Marceau
Michael Marceau
SMSophie Mangenot
Sophie Mangenot
DRDavid Roche
David Roche
CRCarine Rouanet
Carine Rouanet
RBRoland Brosch
Roland Brosch
Roland Brosch and colleagues report whole-genome sequencing of tubercle bacilli with smooth colony morphology, also known as Mycobacterium canetti and/or Mycobacterium prototuberculosis, obtained from humans with tuberculosis from geographically diverse regions. Their comparative genomic analysis with Mycobacterium tuberculosis and other M. tuberculosis complex members identifies extensive recombination and provides insights into the evolution of mycobacteria. The authors also report that tubercle bacilli with smooth colony morphology show reduced persistence and virulence compared to M. tuberculosis strains in infection experiments in mice. Global spread and limited genetic variation are hallmarks of M. tuberculosis, the agent of human tuberculosis. In contrast, Mycobacterium canettii and related tubercle bacilli that also cause human tuberculosis and exhibit unusual smooth colony morphology are restricted to East Africa. Here, we sequenced and analyzed the whole genomes of five representative strains of smooth tubercle bacilli (STB) using Sanger (4–5× coverage), 454/Roche (13–18× coverage) and/or Illumina DNA sequencing (45–105× coverage). We show that STB isolates are highly recombinogenic and evolutionarily early branching, with larger genome sizes, higher rates of genetic variation, fewer molecular scars and distinct CRISPR-Cas systems relative to M. tuberculosis. Despite the differences, all tuberculosis-causing mycobacteria share a highly conserved core genome. Mouse infection experiments showed that STB strains are less persistent and virulent than M. tuberculosis. We conclude that M. tuberculosis emerged from an ancestral STB-like pool of mycobacteria by gain of persistence and virulence mechanisms, and we provide insights into the molecular events involved.

17 August 2007 in Science
Verified
Journal Article
Closed access
PDF file
BCBernard Clantin
Bernard Clantin
ADAnne-Sophie Delattre
Anne-Sophie Delattre
PRPrakash Rucktooa
Prakash Rucktooa
NSNathalie Saint
Nathalie Saint
AMAlbano Meli
Albano Meli
VVVincent Villeret
Vincent Villeret
In Gram-negative bacteria and eukaryotic organelles, β-barrel proteins of the outer membrane protein 85–two-partner secretion B (Omp85-TpsB) superfamily are essential components of protein transport machineries. The TpsB transporter FhaC mediates the secretion of Bordetella pertussis filamentous hemagglutinin (FHA). We report the 3.15 Å crystal structure of FhaC. The transporter comprises a 16-stranded β barrel that is occluded by an N-terminal α helix and an extracellular loop and a periplasmic module composed of two aligned polypeptide-transport–associated (POTRA) domains. Functional data reveal that FHA binds to the POTRA 1 domain via its N-terminal domain and likely translocates the adhesin-repeated motifs in an extended hairpin conformation, with folding occurring at the cell surface. General features of the mechanism obtained here are likely to apply throughout the superfamily.

7 July 2006 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
NMNathalie Mielcarek
Nathalie Mielcarek
ADAnne-Sophie Debrie
Anne-Sophie Debrie
DRDominique Raze
Dominique Raze
JBJulie Bertout
Julie Bertout
CRCarine Rouanet
Carine Rouanet
CLCamille Locht
Camille Locht
Pertussis is still among the principal causes of death worldwide, and its incidence is increasing even in countries with high vaccine coverage. Although all age groups are susceptible, it is most severe in infants too young to be protected by currently available vaccines. To induce strong protective immunity in neonates, we have developed BPZE1, a live attenuated Bordetella pertussis strain to be given as a single-dose nasal vaccine in early life. BPZE1 was developed by the genetic inactivation or removal of three major toxins. In mice, BPZE1 was highly attenuated, yet able to colonize the respiratory tract and to induce strong protective immunity after a single nasal administration. Protection against B. pertussis was comparable to that induced by two injections of acellular vaccine (aPV) in adult mice, but was significantly better than two administrations of aPV in infant mice. Moreover, BPZE1 protected against Bordetella parapertussis infection, whereas aPV did not. BPZE1 is thus an attractive vaccine candidate to protect against whooping cough by nasal, needle-free administration early in life, possibly at birth. Although vaccination has strongly reduced the incidence of whooping cough in many countries, this disease still causes approximately 300,000 deaths per year, mainly in young children that are not fully vaccinated. Efficient protection against pertussis requires at least three vaccine doses and is not achieved before the age of 6 mo. A new strategy to induce strong protective immunity in neonates is to mimic as closely as possible natural infection without inducing the disease, by the use of a live attenuated B. pertussis strain to be given as a single-dose nasal vaccine. The authors examined in the mouse model the efficacy of a genetically attenuated strain, BPZE1. This strain colonizes the mouse respiratory tract, but appears to be highly attenuated as evidenced by histopathological studies. In addition, a single nasal administration of this strain protects against challenge with virulent B. pertussis better than two administrations of acellular vaccine in infant mice. Moreover, BPZE1 provides protection against infection with Bordetella parapertussis responsible for a milder pertussis-like syndrome, which was not seen after vaccination with acellular vaccine. These results show that BPZE1 could be an efficient, single-dose nasal vaccine to protect early in life against whooping cough.

4 August 2011 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
CLCamille Locht
Camille Locht
LCLoic Coutte
Loic Coutte
NMNathalie Mielcarek
Nathalie Mielcarek

3 May 2009 in Nature Medicine
Verified
Journal Article
Closed access
NWNicolas Willand
Nicolas Willand
BDBertrand Dirié
Bertrand Dirié
XCXavier Carette
Xavier Carette
PBPablo Bifani
Pablo Bifani
ASAmit Singhal
Amit Singhal
NWNicolas Willand
Nicolas Willand